drug
FG-3246
Phase 3updated 6mo agoby $KYNB KYNTRA BIO, INC.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying FG-3246
News(1)
- Kyntra axes mid-stage ADC, adding to years of stumblesBeleaguered Kyntra Bio can’t catch a break. Formerly known as FibroGen, the company has endured a series of woes over the last few years, and now the biotech is cutting a clinical antibody-drug con…fiercebiotech · 2d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that